Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Omicxhealth Inc. has 1 pending office action in Biotechnology & Pharmaceuticals. The matter is assigned to 1 examiner and 1 art unit, creating a single prosecution path.
AUGER, NOAH ANDREW is the assigned examiner, with 1 pending matter. Counsel can focus on the application record and the examination practice of that art unit without needing broader portfolio coordination.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| AUGER, NOAH ANDREW | 1 | 36.2% | +42.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19572180 | MEDIUM-DEPTH WHOLE GENOME BISULFITE SEQUENCING ANALYSIS SYSTEM THAT INTEGRATES CLASSIFICATION MODELS TRAINED ON DISPARATE DATASETS | AUGER, NOAH ANDREW | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19572180 | MEDIUM-DEPTH WHOLE GENOME BISULFITE SEQUENCING ANALYSIS SYSTEM THAT INTEGRATES CLASSIFICATION MODELS TRAINED ON DISPARATE DATASETS | AUGER, NOAH ANDREW | — |
| Art Unit | Apps |
|---|---|
| 1687 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19572180 | MEDIUM-DEPTH WHOLE GENOME BISULFITE SEQUENCING ANALYSIS SYSTEM THAT INTEGRATES CLASSIFICATION MODELS TRAINED ON DISPARATE DATASETS | AUGER, NOAH ANDREW | 1687 | §101§112 | Final Rejection | — | Pending | Mar 19, 2026 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialOmicxhealth Inc. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
Noah Andrew Auger has the most, with 1 of Omicxhealth Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.